We are thrilled to announce that the Latin American Trials and Research Network (LATIN) is now part of the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC). LATIN is a network of sites with arboviral acute febrile illness monitoring and clinical trial capabilities with the goal of epidemic preparedness to identify outbreaks and fast track therapies.
The International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) is a global federation of investigator-led clinical research networks—a network of networks. ISARIC has over 70 member networks and numerous partners worldwide. Together, we conduct clinical research to improve patient care and facilitate a globally coordinated and agile research response to infectious disease threats.
For over a decade, they have been generating clinically meaningful research evidence for diseases including COVID-19, dengue, Ebola, Lassa fever, Nipah, Mpox, and bubonic plague, and now our lab is proud to announce that we are joining such an exciting initiative here at GW!
